These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34046448)
21. Alkaloid-metal based anticancer agents. Chen ZF; Liu YC; Huang KB; Liang H Curr Top Med Chem; 2013; 13(17):2104-15. PubMed ID: 23978139 [TBL] [Abstract][Full Text] [Related]
22. Development and current status of unconventional platinum anticancer complexes. Abu-Surrah AS Mini Rev Med Chem; 2007 Feb; 7(2):203-11. PubMed ID: 17305594 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity. Giorgi E; Mannelli M; Gamberi T; Durante M; Gabbiani C; Cirri D; Pratesi A J Inorg Biochem; 2024 Feb; 251():112452. PubMed ID: 38070433 [TBL] [Abstract][Full Text] [Related]
24. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes. Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742 [TBL] [Abstract][Full Text] [Related]
25. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity. Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807 [TBL] [Abstract][Full Text] [Related]
26. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives. Jurgens S; Kuhn FE; Casini A Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319 [TBL] [Abstract][Full Text] [Related]
27. "Good Fashion is Evolution, Not Revolution" - Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal. Guzowska M; Kalinowska M; Lewandowski W Anticancer Agents Med Chem; 2018; 18(4):476-487. PubMed ID: 29189181 [TBL] [Abstract][Full Text] [Related]
28. Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents. Misirlic-Dencic S; Poljarevic J; Isakovic AM; Sabo T; Markovic I; Trajkovic V Curr Med Chem; 2020; 27(3):380-410. PubMed ID: 30378486 [TBL] [Abstract][Full Text] [Related]
29. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives. Abeysinghe PM; Harding MM Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034 [TBL] [Abstract][Full Text] [Related]
32. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium. Zou T; Lok CN; Wan PK; Zhang ZF; Fung SK; Che CM Curr Opin Chem Biol; 2018 Apr; 43():30-36. PubMed ID: 29136524 [TBL] [Abstract][Full Text] [Related]
33. Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes. Abás E; Aguirre-Ramírez D; Laguna M; Grasa L Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944591 [TBL] [Abstract][Full Text] [Related]
34. Titanium and vanadium complexes as anticancer agents. Kostova I Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167 [TBL] [Abstract][Full Text] [Related]
35. Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs. Doucette KA; Hassell KN; Crans DC J Inorg Biochem; 2016 Dec; 165():56-70. PubMed ID: 27751591 [TBL] [Abstract][Full Text] [Related]
36. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections. Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647 [TBL] [Abstract][Full Text] [Related]
37. Selectivity of the highly preorganized tetradentate ligand 2,9-di(pyrid-2-yl)-1,10-phenanthroline for metal ions in aqueous solution, including lanthanide(III) ions and the uranyl(VI) cation. Carolan AN; Cockrell GM; Williams NJ; Zhang G; VanDerveer DG; Lee HS; Thummel RP; Hancock RD Inorg Chem; 2013 Jan; 52(1):15-27. PubMed ID: 23231454 [TBL] [Abstract][Full Text] [Related]
38. A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin. De Luca A; Hartinger CG; Dyson PJ; Lo Bello M; Casini A J Inorg Biochem; 2013 Feb; 119():38-42. PubMed ID: 23183361 [TBL] [Abstract][Full Text] [Related]
39. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action. Lima JC; Rodriguez L Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238 [TBL] [Abstract][Full Text] [Related]
40. Photoactivation of the Cytotoxic Properties of Platinum(II) Complexes through Ligand Photoswitching. Presa A; Vázquez G; Barrios LA; Roubeau O; Korrodi-Gregório L; Pérez-Tomás R; Gamez P Inorg Chem; 2018 Apr; 57(7):4009-4022. PubMed ID: 29543468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]